Jon Chung
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
Papers in
-
- Cancer Genomics and Diagnostics 23
- Breast Cancer Treatment Studies 4
-
- Lung Cancer Treatments and Mutations 11
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 5
- Co-authors
- Siraj Mahamed Ali (36 shared papers)Jeffrey S. Ross (33 shared papers)Vincent A. Miller (20 shared papers)Fred Bunz (7 shared papers)Alexa Betzig Schrock (24 shared papers)Andrea Necchi (14 shared papers)Garrett Michael Frampton (10 shared papers)Philip J. Stephens (8 shared papers)
- Journals
- Annals of Oncology (17 papers)JCO Precision Oncology (8 papers)European Urology (6 papers)Clinical Cancer Research (4 papers)The Oncologist (4 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Jon Chung
73 papers receiving 4k citations
Jon Chung's Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 742
- Oncology 1k
- Pulmonary and Respiratory Medicine 935
- Surgery 1.3k
- Genetics 246
Countries citing papers authored by Jon Chung
This map shows the geographic impact of Jon Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Chung more than expected).
Fields of papers citing papers by Jon Chung
This network shows the impact of papers produced by Jon Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Chung. The network helps show where Jon Chung may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Chung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study Hit paper breakdown → | 2018 | 557 |
| 2 | 2019 | 268 | |
| 3 | Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies Hit paper breakdown → | 2019 | 266 |
| 4 | 2018 | 175 | |
| 5 | 2021 | 164 | |
| 6 | 2020 | 136 | |
| 7 | 2019 | 131 | |
| 8 | 2020 | 118 | |
| 9 | 2018 | 98 | |
| 10 | 2017 | 95 | |
| 11 | 2017 | 92 | |
| 12 | 2019 | 90 | |
| 13 | 2010 | 86 | |
| 14 | 2018 | 85 | |
| 15 | 2016 | 84 | |
| 16 | 2016 | 82 | |
| 17 | 2014 | 81 | |
| 18 | 2020 | 81 | |
| 19 | 2018 | 79 | |
| 20 | 2017 | 76 |
About Jon Chung
Jon Chung is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Surgery and Molecular Biology, having authored 73 papers that have together received 4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (23 papers), Bladder and Urothelial Cancer Treatments (14 papers), Lung Cancer Treatments and Mutations (11 papers), Prostate Cancer Treatment and Research (5 papers), Renal cell carcinoma treatment (5 papers), Testicular diseases and treatments (4 papers), DNA Repair Mechanisms (4 papers) and Breast Cancer Treatment Studies (4 papers). The work is most often cited by research in Cancer Research (742 citations), Oncology (1k citations), Pulmonary and Respiratory Medicine (935 citations), Surgery (1.3k citations) and Genetics (246 citations). Jon Chung has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Siraj Mahamed Ali, Jeffrey S. Ross, Vincent A. Miller, Fred Bunz, Alexa Betzig Schrock, Andrea Necchi, Garrett Michael Frampton, Philip J. Stephens, Sumanta Kumar Pal and Russell William Madison. Their work appears in journals such as Annals of Oncology, JCO Precision Oncology, European Urology, Clinical Cancer Research and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.